Globe Life Inc. (NYSE:GL – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eleven analysts that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $191.6667.
A number of research analysts have commented on the stock. Wells Fargo & Company raised their target price on shares of Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research report on Thursday, July 9th. TD Cowen upped their price target on shares of Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Jefferies Financial Group increased their price objective on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research note on Friday, July 10th. Piper Sandler lifted their price objective on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. Finally, Morgan Stanley boosted their price objective on shares of Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research note on Monday, July 6th.
Read Our Latest Stock Analysis on Globe Life
Globe Life Stock Performance
Globe Life (NYSE:GL – Get Free Report) last released its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.73%. The firm had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the firm earned $3.05 earnings per share. The business’s revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, equities research analysts expect that Globe Life will post 15.7 earnings per share for the current fiscal year.
Insider Buying and Selling
In other news, EVP Michael Clay Majors sold 37,000 shares of Globe Life stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $178.64, for a total value of $6,609,680.00. Following the transaction, the executive vice president directly owned 53,518 shares in the company, valued at approximately $9,560,455.52. This trade represents a 40.88% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Cheryl Alston sold 8,258 shares of the business’s stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $179.24, for a total value of $1,480,163.92. Following the completion of the transaction, the director directly owned 16,621 shares of the company’s stock, valued at approximately $2,979,148.04. The trade was a 33.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 169,174 shares of company stock worth $28,553,849 over the last quarter. Insiders own 2.11% of the company’s stock.
Hedge Funds Weigh In On Globe Life
Large investors have recently added to or reduced their stakes in the company. CYBER HORNET ETFs LLC bought a new stake in shares of Globe Life in the 2nd quarter valued at about $28,000. Hilton Head Capital Partners LLC bought a new position in shares of Globe Life during the 4th quarter worth approximately $30,000. MUFG Securities EMEA plc bought a new position in shares of Globe Life during the 2nd quarter worth approximately $31,000. Torren Management LLC purchased a new stake in Globe Life during the fourth quarter valued at approximately $37,000. Finally, AdvisorNet Financial Inc lifted its position in Globe Life by 41.1% during the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after acquiring an additional 92 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors.
About Globe Life
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Further Reading
- Five stocks we like better than Globe Life
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
